Correlation Between Zosano Pharma and Abrdn Bloomberg

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Zosano Pharma and Abrdn Bloomberg at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zosano Pharma and Abrdn Bloomberg into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zosano Pharma Corp and abrdn Bloomberg All, you can compare the effects of market volatilities on Zosano Pharma and Abrdn Bloomberg and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zosano Pharma with a short position of Abrdn Bloomberg. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zosano Pharma and Abrdn Bloomberg.

Diversification Opportunities for Zosano Pharma and Abrdn Bloomberg

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Zosano and Abrdn is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Zosano Pharma Corp and abrdn Bloomberg All in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on abrdn Bloomberg All and Zosano Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zosano Pharma Corp are associated (or correlated) with Abrdn Bloomberg. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of abrdn Bloomberg All has no effect on the direction of Zosano Pharma i.e., Zosano Pharma and Abrdn Bloomberg go up and down completely randomly.

Pair Corralation between Zosano Pharma and Abrdn Bloomberg

If you would invest (100.00) in Zosano Pharma Corp on January 19, 2024 and sell it today you would earn a total of  100.00  from holding Zosano Pharma Corp or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Zosano Pharma Corp  vs.  abrdn Bloomberg All

 Performance 
       Timeline  
Zosano Pharma Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zosano Pharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Zosano Pharma is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
abrdn Bloomberg All 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in abrdn Bloomberg All are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent fundamental indicators, Abrdn Bloomberg may actually be approaching a critical reversion point that can send shares even higher in May 2024.

Zosano Pharma and Abrdn Bloomberg Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Zosano Pharma and Abrdn Bloomberg

The main advantage of trading using opposite Zosano Pharma and Abrdn Bloomberg positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zosano Pharma position performs unexpectedly, Abrdn Bloomberg can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abrdn Bloomberg will offset losses from the drop in Abrdn Bloomberg's long position.
The idea behind Zosano Pharma Corp and abrdn Bloomberg All pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance